OTC Sales Growth Booster: Match Launches With Consumer Needs
This article was originally published in The Tan Sheet
More flavors and package redesigns briefly grab consumers’ attention, but innovative and truly new product launches that address their needs will accelerate OTC industry sales growth, which has held steady at 3% annually since 2010, an IRI Worldwide marketing insider says.
You may also be interested in...
Merck’s Oxytrol for Women could set the stage for other OTC switches indicated for chronic conditions, but the lifestyle changes recommended with the drug could be a hurdle. Oxytrol faces similar challenges to alli, another first-in-class switch with behavioral changes recommended.
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.